Growth and Cell Survival Following Treatment with Estramustine, Nor-Nitrogen Mustard, Estradiol and Testosterone of a Human Prostatic Cancer Cell Line (DU 145)
- 1 April 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 127 (4) , 818-822
- https://doi.org/10.1016/s0022-5347(17)54057-4
Abstract
Estramustine at concentrations ranging from 3-40 .times. 10-6 M inhibited the cell growth and clonogenic survival of a human prostatic carcinoma cell line (DU 145). This cell line was unresponsive to estradiol and testosterone at concentrations ranging from 10-9 M to 5 .times. 10-5 M. Metabolism studies with estramustine showed that only a low percentage of the ester linkage was cleaved during the exposure period. This small amount of metabolism could possibly lead to the release of nor-nitrogen mustard, which was found not to be as inhibitory as estramustine in this cell line. Apparently, estramustine per se causes the cell death of hormone unresponsive human prostatic carcinoma cells in cell culture.This publication has 20 references indexed in Scilit:
- Chemotherapy of Advanced, Hormonally Resistant Prostatic CarcinomaOncology, 1980
- Estracyt Therapy of Advanced Prostatic Cancer with Special Reference to Control of Therapy with Cytology and DNA CytophotometryEuropean Urology, 1980
- Effect of estramustine phosphate (Estracyt®) on transplantable mouse tumoursUrological Research, 1979
- Pilot Study on the Growth Inhibition by Estramustine Phosphate (Estracyt®) of Rat Mammary Tumours Sensitive and Insensitive to OestrogenActa Pharmacologica et Toxicologica, 1979
- Letter to the editorInternational Journal of Cancer, 1978
- Isolation of a human prostate carcinoma cell line (DU 145)International Journal of Cancer, 1978
- Estramustine Phosphate: A Specific Chemotherapeutic Agent?Journal of Urology, 1977
- Estramustine Phosphate Therapy in Carcinoma of the ProstatePublished by Springer Nature ,1977
- Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)Scandinavian Journal of Urology and Nephrology, 1977
- Variability of Hormone Concentrations and Ratios in Commercial Sera Used for Tissue Culture2JNCI Journal of the National Cancer Institute, 1973